We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+11.22%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.92B
AUM Growth
-$861M
(-31%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-56.34%
Top 10 Holdings %
Top 10 Hldgs %
24.9%
Holding
1,961
New
419
Increased
272
Reduced
381
Closed
669
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KE Holdings
BEKE
|
+$13.6M |
| 2 |
TSMC
TSM
|
+$11.4M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$11.3M |
| 4 |
Applied Materials
AMAT
|
+$9.44M |
| 5 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
+$6.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KAHC
KKR Acquisition Holdings I Corp.
KAHC
|
+$30.7M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$30.3M |
| 3 |
Y
Alleghany Corp
Y
|
+$24.9M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$17M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.05% |
| 2 | Technology | 12.34% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Industrials | 7.99% |
| 5 | Healthcare | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCBO
676
Docebo
DCBO
$594M
| $387K | 0.02% |
11,708
| – | – |
|
|
ARTEU
677
DELISTED
Artemis Strategic Investment Corporation Unit
ARTEU
| $387K | 0.02% |
38,253
| – | – |
|
|
SPNE
678
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $387K | 0.02% |
+46,289
| New | +$312K |
|
679
CALL
VanEck Semiconductor ETF
SMH
$70.1B
| $386K | 0.02% |
+3,800
| New | +$386K |
|
680
Vertex Pharmaceuticals
VRTX
$133B
| $385K | 0.02% |
+1,334
| New | +$407K |
|
681
Adobe
ADBE
$109B
| $385K | 0.02% |
1,144
-2,472
| -68% | -$791K |
|
|
FSTX
682
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $384K | 0.02% |
60,807
+41,719
| +219% | +$231K |
|
683
CEMIG Preferred Shares
CIG
$5.84B
| $383K | 0.02% |
245,330
+3,202
| +1% | +$5.15K |
|
684
CALL
New Oriental
EDU
$9.24B
| $383K | 0.02% |
11,000
-200
| -2% | -$5.65K |
|
685
BRC Inc
BRCC
$216M
| $383K | 0.02% |
62,676
+51,076
| +440% | +$333K |
|
|
STKL
686
DELISTED
SunOpta
STKL
| $383K | 0.02% |
45,355
-6,601
| -13% | -$62.3K |
|
687
Quanterix
QTRX
$114M
| $381K | 0.02% |
27,475
+8,185
| +42% | +$94.2K |
|
|
PPYA
688
DELISTED
Papaya Growth Opportunity Corp. I Class A Common Stock
PPYA
| $379K | 0.02% |
37,104
+4
| +0% | +$40 |
|
689
Autodesk
ADSK
$54.1B
| $379K | 0.02% |
2,026
-186
| -8% | -$37.3K |
|
|
LDHAU
690
DELISTED
LDH Growth Corp I Units
LDHAU
| $378K | 0.02% |
37,510
| – | – |
|
691
Colliers International
CIGI
$5.11B
| $375K | 0.02% |
4,076
+1,221
| +43% | +$113K |
|
692
Denison Mines
DNN
$2.95B
| $374K | 0.02% |
325,300
| – | – |
|
693
MaxLinear
MXL
$6.21B
| $372K | 0.02% |
+10,955
| New | +$371K |
|
694
Revvity
RVTY
$12.9B
| $371K | 0.02% |
+2,647
| New | +$356K |
|
695
Golar LNG
GLNG
$5.16B
| $371K | 0.02% |
16,277
-8,084
| -33% | -$202K |
|
|
ISEE
696
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $370K | 0.02% |
+17,297
| New | +$369K |
|
697
CALL
NVIDIA
NVDA
$5.27T
| $365K | 0.02% |
+25,000
| New | +$367K |
|
698
Digi International
DGII
$3.14B
| $365K | 0.02% |
9,993
+1,023
| +11% | +$39.4K |
|
699
Royal Caribbean
RCL
$82.4B
| $365K | 0.02% |
7,385
-9,200
| -55% | -$482K |
|
|
EBTC
700
DELISTED
Enterprise Bancorp
EBTC
| $365K | 0.02% |
10,338
-1,808
| -15% | -$59.6K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Prelude Capital Management held 1,961 positions worth $1.92B, down 31% from $2.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Prelude Capital Management withdrew a net $1.08B in Q4 2022, closing 669 positions and reducing 381 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $30.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Prelude Capital Management opened a new position in AVEO Pharmaceuticals, Inc. worth $7.55M.
- Prelude Capital Management's largest Q4 2022 buy was AVEO Pharmaceuticals, Inc.: 504,972 shares worth $7.55M.
- Prelude Capital Management added most to KE Holdings in Q4 2022, an estimated $13.6M increase.
- Prelude Capital Management's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $6.9M.
- Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $30.7M.
- Prelude Capital Management's ten largest holdings make up 25% of its $1.92B portfolio in Q4 2022.
- Prelude Capital Management opened 419 new positions and closed 669 in Q4 2022.
- Prelude Capital Management's portfolio value fell 31% quarter-over-quarter to $1.92B.
Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.